Wealth Enhancement Advisory Services
MBOT icon

Wealth Enhancement Advisory Services’s Microbot Medical MBOT Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio MBOT Stock Details MBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$42.1K Buy
+22,279
New +$45.4K ﹤0.01% 3946

Other funds holding MBOT

BL
BFSG LLC Irvine, California $1.13B AUM 29.95% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
WAG
Wilkerson Advisory Group Columbia, Missouri $326M AUM
WWM
Wolff Wiese Magana Carslbad, California $217M AUM 47.64% 1-Year Est. Return

Wealth Enhancement Advisory Services's MBOT Position: Q2 2026 in Review

Wealth Enhancement Advisory Services opened a new position in Microbot Medical (MBOT) in Q2 2026: 22,279 shares worth $42.1K. The stake represents ﹤0.01% of the portfolio and ranks #3946 among its holdings.

5 funds tracked by Wall St. Rank hold MBOT as of Q2 2026.

  • Wealth Enhancement Advisory Services held 22,279 shares of Microbot Medical worth $42.1K as of Q2 2026.
  • Microbot Medical was a new Wealth Enhancement Advisory Services position in Q2 2026.
  • Microbot Medical made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #3946 holding.
  • 5 funds tracked by Wall St. Rank held Microbot Medical as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.